Prevalence Survey of Healthcare Associated Infections (HAIs) and Antimicrobial Use in U.S. Acute Care Hospitals

Forms and Documents

Document Name	Status
Form 1 EIP Personnel Prevalence Survey #2, Phase #3 Form	New
Form 1 Infection Control Practioners Prevalence Survey #2, Phase 3 Form	New
Form 1 EIP Personnel Prevalence Survey #1, Phase 2 Form	New
Form 1 Infection Control Practioners Prevalence Survey #1, Phase 2 Form	New
0920-09AM HAI Prevalence Survey Supporting Statement Part B 02 17 2010.doc Supporting Statement B	2010-03-19
2010-4885.pdf Supplementary Document	2010-03-12
Attachment D ARRA.pdf Supplementary Document	2010-03-12
Attachment B 60 day FRN.pdf Supplementary Document	2010-03-12
0920-09AM HAI Prevalence Survey Supporting Statement Part A clean 05 11 2010.doc Supporting Statement A	2010-05-11

IC Document Collections

IC ID	Document Title	Status
192454	EIP Personnel Prevalence Survey #2, Phase #3 Form	New
192453	Infection Control Practioners Prevalence Survey #2, Phase 3 Form	New
192452	EIP Personnel Prevalence Survey #1, Phase 2 Form	New
192451	Infection Control Practioners Prevalence Survey #1, Phase 2 Form	New

ICR Details

OMB Control No: 0920-0852	ICR Reference No: 201004-0920-002
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: HHS/CDC	Agency Tracking No:
Title: Prevalence Survey of Healthcare Associated Infections (HAIs) and Antimicrobial Use in U.S. Acute Care Hospitals
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 05/18/2010
	Date Received in OIRA: 04/05/2010
Terms of Clearance: OMB approves Phase 2 of this research (the limited roll-out survey in up to 30 healthcare facilities.) CDC must submit a change package for Phase 3. The package for Phase 3 must define the scope (i.e., whether facilities outside of usual EIP catchment areas will be included) as well as the results of discussions with NCHS about using the 10 EIPs areas to characterize a national estimate.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	05/31/2013	36 Months From Approved
Responses	61,480	0	0
Time Burden (Hours)	8,039	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: The Centers for Disease Control and Prevention (CDC) proposes to conduct two surveys to evaluate the prevalence of healthcare-associated infections (HAIs) and antimicrobial use in acute care hospitals in multiple states. This is a three-phase project. The first phase, a small, single-city pilot survey with less than 9 respondents, is complete. Phases 2 and 3 will be conducted in collaboration with state public health authorities and with CDC's Emerging Infections Program (EIP). Phase 2 will be a limited roll-out survey involving up to 30 healthcare facilities in the 10 states with EIP sites. Phase 3, built upon experience gained in the limited roll-out, will involve up to 500 facilities in the 10 states with EIP sites using the same survey. CDC does not anticipate making changes to the data collection instrument in Phase 3.

---

Authorizing Statute(s): PL: Pub.L. 111 - 5 1 Name of Law: American Recovery and Reinvestment Act of 2009
   US Code: 42 USC 241 Name of Law: Public Health Service Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	75 FR 4396	01/27/2010
30-day Notice:	Federal Register Citation:	Citation Date:
	75 FR 10803	03/09/2010
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 4

IC Title	Form No.	Form Name
Infection Control Practioners Prevalence Survey #1, Phase 2	1	2010 HAI & Antimicrobial Use Point Prevalence Survey: Primary Team Data Collection Form
EIP Personnel Prevalence Survey #1, Phase 2	1	2010 HAI & Antimicrobial Use Point Prevalence Survey: Primary Team Data Collection Form
Infection Control Practioners Prevalence Survey #2, Phase 3	1	2010 HAI & Antimicrobial Use Point Prevalence Survey: Primary Team Data Collection Form
EIP Personnel Prevalence Survey #2, Phase #3	1	2010 HAI & Antimicrobial Use Point Prevalence Survey: Primary Team Data Collection Form

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	61,480	0	0	61,480	0	0
Annual Time Burden (Hours)	8,039	0	0	8,039	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: This is a new ICR submission funded under the American Recovery and Reinvestment Act of 2009.

---

Annual Cost to Federal Government: $111,384

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? Yes

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Yes

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 04/05/2010

---